...
首页> 外文期刊>Journal of epidemiology / >Difference of Progression to AIDS According to CD4 Cell Count, Plasma HIV RNA Level and the Use of Antiretroviral Therapy among HIV Patients Infected through Blood Products in Japan
【24h】

Difference of Progression to AIDS According to CD4 Cell Count, Plasma HIV RNA Level and the Use of Antiretroviral Therapy among HIV Patients Infected through Blood Products in Japan

机译:在日本通过血液制品感染的HIV患者中,根据CD4细胞计数,血浆HIV RNA水平和抗逆转录病毒疗法的不同,艾滋病进展的差异

获取原文

摘要

BACKGROUND: It is important to examine progression to acquired immunodeficiency syndrome (AIDS) or death and its predictors among human immunodeficiency virus (HIV) infected persons before and after the introduction of the highly active antiretroviral therapy (HAART) available in Japan since 1997. METHODS: The data used were from a survey of persons with HIV infected through blood coagulation factor products in Japan. Progression to AIDS or death during two periods, between January 1994 and March 1997, and between April 1997 and March 2002, were observed. RESULTS: The AIDS-free proportion after 3 years was 74% among 417 participants for the earlier period and 94% among 605 participants in the later one. The hazard ratio of low CD4 cell count (less than 200 cells/μL) was 50.8 for the earlier period and 4.7 for the later one compared with that of 500 cells/μL or more. After adjustment by plasma HIV RNA levels and use of antiretroviral therapy, the hazard ratios of the low CD4 cell count for the later period were still significant. CONCLUSION: The AIDS-free proportion among people with HIV infected through blood products in Japan largely increased after the introduction of HAART. The CD4 cell count remains an important predictor of future progression, but its importance might be less because of HAART. J Epidemiol 2006; 16: 101-106.
机译:背景:从1997年开始在日本开始采用高效抗逆转录病毒疗法(HAART)之前和之后,检查在人类免疫缺陷病毒(HIV)感染者中获得性免疫缺陷综合症(AIDS)或死亡的进展及其预测因素是很重要的。 :使用的数据来自对日本通过凝血因子产品感染HIV的人群的调查。观察到在1994年1月至1997年3月以及1997年4月至2002年3月的两个时期内艾滋病或死亡的进展。结果:较早阶段的417名参与者中,3年后无艾滋病的比例为74%,较晚阶段的605名参与者中为94%。低CD4细胞计数(小于200个细胞/μL)的危险比在早期为50.8,在后期为4.7,而500个细胞/μL或更高。在通过血浆HIV RNA水平进行调整并使用抗逆转录病毒疗法后,后期CD4细胞计数低的危险比仍然很大。结论:引入HAART后,在日本通过血液制品感染的艾滋病毒感染者中无艾滋病的比例大大增加。 CD4细胞计数仍然是未来进展的重要预测指标,但由于HAART,其重要性可能会降低。流行病杂志2006; 16:101-106。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号